Women's Health

Women remain at significantly higher risk than men for adverse outcomes after coronary artery bypass grafting with no substantial improvements observed in the last decade, according to a retrospective cohort study published in JAMA Surgery.

CVD is responsible for approximately one in three deaths among women in the U.S. each year, yet only 38% of participants in clinical CVD trials are women, according to the American Heart Association.

Research suggests that women are more vulnerable to common mental health conditions compared with men at all stages of the life course, which can also have important implications for CVD risk.

Menopausal hormone therapy for bothersome vasomotor or other symptoms is safe and appropriate for most women at low atherosclerotic CVD risk, whereas a nuanced approach is needed for intermediate-risk women, researchers reported.

Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.

Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.

Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.

Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.

Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.